Access
To read this story in full you will need to login or make a payment (see right).
Brief Communications
Nature 418, 934 (29 August 2002) | doi:10.1038/418934a
Open Innovation Challenges
-
Fast Growth of Transformed Soybean Shoots
A method for accelerating growth of soybean shoots is desired.
-
Efficient Chromosome Doubling: Plant Cell Division
The Seeker is looking for an efficient chromosome doubling method in plants and in particular, metho...
nature jobs
Principal Scientist - Pain in Vitro Cell Biologist
- GlaxoSmithKline
- Harlow, Essex United Kingdom
Executive Director
- Pennington Biomedical Research Center
- Baton Rouge, Louisiana, USA
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status
Harith Rajagopalan, Alberto Bardelli2, Christoph Lengauer, Kenneth W. Kinzler, Bert Vogelstein & Victor E. Velculescu
Abstract
Genes of the RAF family encode kinases that are regulated by Ras and mediate cellular responses to growth signals. Activating mutations in one RAF gene, BRAF, have been found in a high proportion of melanomas and in a small fraction of other cancers1. Here we show that BRAF mutations in colorectal cancers occur only in tumours that do not carry mutations in a RAS gene known as KRAS, and that BRAF mutation is linked to the proficiency of these tumours in repairing mismatched bases in DNA. Our results not only provide genetic support for the idea that mutations in BRAF and KRAS exert equivalent effects in tumorigenesis2, but also emphasize the role of repair processes in establishing the mutation spectra that underpin human cancer.
To read this story in full you will need to login or make a payment (see right).

